Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Paul Rosenblatt"'
Autor:
Kent C. Shih, Sajeel Chowdhary, Gregg C. Shepard, John D. Hainsworth, Alva B. Weir, Howard A. Burris, Mythili Shastry, Paul Rosenblatt, Jeffrey T. Williams
Publikováno v:
Journal of neuro-oncology. 129(2)
Meningiomas that progress after standard therapies are challenging with limited effective chemotherapy options. This phase II trial evaluated the efficacy of everolimus plus bevacizumab in patients with recurrent, progressive meningioma after treatme
Autor:
Larry Schlabach, Yu Shyr, Hak Choy, David H. Johnson, Lester Porter, Kenneth R. Hande, Russell F. DeVore, Furhan Yunus, Paul Rosenblatt, Clyde Smith
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 47:931-937
Purpose: We conducted a prospective phase II study to determine the response rate, toxicity, and survival rate of concurrent weekly paclitaxel, carboplatin, and hyperfractionated radiation therapy (paclitaxel/carboplatin/HFX RT) followed by 2 cycles
Autor:
David H. Johnson, B. Slovis, Lester Porter, Hak Choy, Kenneth R. Hande, K. Laporte, Russell F. DeVore, Yu Shyr, Paul Rosenblatt
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 34(3)
Purpose: Docetaxel, an active agent for non-small cell lung cancer (NSCLC), has demonstrated activity as a radiosensitizer in numerous pre-clinical studies. We conducted a phase I trial to determine the maximum-tolerated dose (MTD) and dose-limiting